UMIN ID: UMIN000002193
Registered date:14/07/2009
The study to evaluate the efficacy and resistance for EGFR-TKIs treatment in lung cancer patients.
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | lung cancer |
Date of first enrollment | 2009/07/01 |
Target sample size | 60 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | EGFR-TKIs, analysis of genomic profiles |
Outcome(s)
Primary Outcome | corrlation of genomic profile and efficacy and resistance |
---|---|
Secondary Outcome | adverse ivent, survival, patinets characteristics |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | except for the above-mentioned |
Related Information
Primary Sponsor | Second Department of Internal Medicine, Nagasaki University hospital |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | None |
Secondary ID(s) |
Contact
public contact | |
Name | |
Address | Japan |
Telephone | 095-819-7273 |
Affiliation | NTOG Nagasaki-university hospital |
scientific contact | |
Name | Yoichi Nakamura |
Address | 1-7-1 Sakamoto, Nagasaki 852-8501, JAPAN Japan |
Telephone | |
Affiliation | Nagasaki-university hospital second depertment of internal medisine |